Cargando…
Nasopharyngeal carcinoma: an EBV-associated tumour not significantly influenced by HIV-induced immunosuppression. The AIDS/Cancer Working Group.
We used a link between cancer (859,398 reports) and AIDS (50,050 reports) registries in the United States to study whether nasopharyngeal carcinoma (NPC) was increased in the population with AIDS. There was no indication of a significantly increased risk up to or after the AIDS diagnosis, which argu...
Autores principales: | Melbye, M., Coté, T. R., West, D., Kessler, L., Biggar, R. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075828/ https://www.ncbi.nlm.nih.gov/pubmed/8611438 |
Ejemplares similares
-
EBV-associated gastric carcinoma in high- and low-incidence areas for nasopharyngeal carcinoma
por: Boysen, T, et al.
Publicado: (2009) -
EBV-EBNA1 constructs an immunosuppressive microenvironment for nasopharyngeal carcinoma by promoting the chemoattraction of Treg cells
por: Huo, Shaofen, et al.
Publicado: (2020) -
Pathogenesis and Diagnostic Significance of EBV-miR-BARTs in Nasopharyngeal Carcinoma
por: Wu, Zhen, et al.
Publicado: (2022) -
Multimodality Management of EBV-Associated Nasopharyngeal Carcinoma
por: Yu, Justin, et al.
Publicado: (2021) -
Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
por: Li, Wenting, et al.
Publicado: (2023)